How much does a bottle of Mitotane cost in India?

Mitotane (Mitotane) is a drug used to treat adrenocortical cancer (Adrenocortical Carcinoma, ACC). Mitotane is a hormone disruptor that treats adrenocortical cancer primarily by disrupting the function of adrenocortical cells. It reduces the secretion of adrenocortical hormones and inhibits the proliferation of adrenocortical cells, thereby slowing tumor growth.

There is currently no officially marketed Indian generic version of Mitotane. Mitotane has not yet been launched in China, so patients cannot purchase it domestically and need to purchase it through overseas channels. There are original drugs and generic drugs abroad. The Turkish version of the original drug is about more than 7,000 yuan, followed by the European version of the original drug, which is about 9,000 yuan. There are also cost-effective generic drugs, mainly Laos and ASEAN generic drugs. The price is about more than 3,000 yuan. The ingredients of the original drugs and generic drugs are the same.

Mitotan is commonly used to treat malignant adrenocortical cancers, especially those that have spread to other sites. It has a role in the first-line treatment of adrenocortical cancer, but often needs to be combined with other treatments such as surgery, radiation therapy, and chemotherapy.

Mitotan is an oral medication, and the dose is usually determined based on the patient's weight and tumor severity. The initial dose is usually between 2-6g per day, divided into 2 to 3 times daily. Doctors will regularly adjust dosages to ensure the drug's effectiveness and minimize side effects. The use of mitotane may be associated with a range of side effects, including nausea, vomiting, diarrhea, skin problems, headache, fatigue, and neurological symptoms. Patients should report any discomfort to their physician for prompt treatment and management.